Skip to main content

stock

KRYS · Krystal Biotech, Inc.

What Krystal Biotech, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live KRYS price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on KRYS.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
29,598,836 as of 2026-07-28 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
44.9%
Net
54.8%

Returns

ROE
17.8%
ROA
16.1%

Health

Current ratio
8.3x
Debt/equity
—

Deep value

NCAV
$918.13M
NCAV per share
$31.02
Price/NCAV
Locked
NNWC
$412.99M
NNWC per share
$13.95
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$119.22M—Gross profit: unreported by this company.$58.42M$54.77M
10-Q filed 2026-08-03
2026-03-31$116.36M—Gross profit: unreported by this company.$53.69M$55.93M
10-Q filed 2026-08-03
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$107.11M—Gross profit: unreported by this company.$44.27M$51.40M
10-K filed 2026-02-17
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$97.80M—Gross profit: unreported by this company.$41.37M$79.36M
10-Q filed 2025-11-03
2025-06-30$96.04M—Gross profit: unreported by this company.$39.40M$38.33M
10-Q filed 2026-08-03
2025-03-31$88.18M—Gross profit: unreported by this company.$36.25M$35.73M
10-Q filed 2026-08-03
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$91.14M—Gross profit: unreported by this company.$41.39M$45.48M
10-K filed 2026-02-17
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$83.84M—Gross profit: unreported by this company.$22.47M$27.18M
10-Q filed 2025-11-03
Assets
$1.50B
Equity
$1.36B

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$389.13M$161.29M$204.83M$188.91M
2024-12-31$290.51M$65.75M$89.16M$119.18M
2023-12-31$50.70M-$109.62M$10.93M-$100.60M
2022-12-31$0-$145.20M-$139.97M-$153.55M
2021-12-31$0-$68.28M-$69.57M-$116.27M
2020-12-31—-$33.00M-$32.17M-$40.93M
2019-12-31—-$22.08M-$19.09M-$25.09M
2018-12-31—-$11.92M-$10.89M-$11.68M
2017-12-31—-$4.77M-$7.92M—
2016-12-31—-$1.14M-$1.15M—

Company filings

events

  • Results

    Results
    Aug 38-K
  • Other event

    Other event
    Jul 218-K
  • Shareholder vote results

    Shareholder vote results
    May 198-K
  • 8-K

    May 48-K
  • Results

    Results
    Feb 178-K
  • Results, Regulation FD disclosure

    ResultsRegulation FD disclosure
    Jan 128-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

News

Stories that named KRYS, and the market events around them.

Sign in to see this

Board

The KRYS board could not be loaded.

Retry the KRYS board

nakagai

Signals on KRYS come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the KRYS board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Krystal Biotech, Inc. (KRYS): SEC filings, financials and insider trades · Nakagai